ARCHIVES

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

Cooperative group Outreach Extended Three ears, Gets Extra $1 Million, Up to Four More Awards

October 28, 1983

NCI Cooperative Group Clinical Trials Approved

August 28, 2009

NCI names Porter Novelli executive as director for strategic dissemination.

August 1, 2003

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

June 22, 2007

Cancer Program Advocate Mary Lasker, 93, Prodded Government, Scientists For Cures

March 4, 1994